Hepatitis C Virus and Human Immunodeficiency Virus-1 Co-Infection in Former Heroin Addicts in Methadone Maintenance Treatment
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT). METHODS: Retrospective chart review for patients (n = 342) currently attending two MMT clinics affiliated with New York Presbyterian Hospital (Adolescent Development Program, ADP: n = 106, median age 30 years; Adult Clinic, AC: n = 236, median age 45 years), as of May 2000. RESULTS: Overall seroprevalence of those tested was 67% for HCV (ADP, 44%; AC, 80%), and 29% for HIV-1 (ADP, 13%, AC, 39%). Co-infection was present in 26% of patients (ADP, 13%; AC, 35%). Prevalence of HCV reached 92% in the 45-49 year old group (n = 53). The greatest HIV-1 prevalence (45%) was in the 35-39 year old group (n = 33). There was a linear relationship between infection seroprevalence and age at admission into MMT. CONCLUSIONS: The high prevalence of HCV and HIV-1 infections in MMT patients varies both by current age and by age at admission to MMT. This population needs risk reduction education and treatment for HCV and HIV- 1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early interventions can prevent the associated consequences of addiction such as HIV and hepatitis C.135”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [135]
Citations
Cites
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Soto, B., Sánchez-Quijano, A., Rodrigo, L., Olmo, J. A. D., García-Bengoechea, M., Hernández-Quero, J., Rey, C., Abad, M. A., Rodríguez, M., Sales Gilabert, M., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80001-3 · Cited by 701
Reichard, O., Norkrans, G., Frydén, A., Braconier, J.-H., Sönnerborg, A., & Weiland, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06088-1 · Cited by 629
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., & Kaplan, E. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00003 · Cited by 347
Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802001-00004 · Cited by 346
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Research works printed but not linked: 8
- Alter M J, 1999, N Eng J Med., 341, 256
- Merrick, S T, Sepkowitz, K A, Boyle, B A and Jacobs, J L. Seroprevalence of hepatitis C antibody and hepatitis B surface antigenemia in a large urban HIV clinic. Programs and Abstracts of the 12th World AIDS Conference (Geneva). Geneva, Switzerland. pp.315 Abstract 22263
- Stubbe, L, Soriano, VAntunes, F. Hepatitis C in the EuroSIDA Cohort of European HIV-infected patients: prevalence and prognostic value. Programs and Abstracts of the 12th World AIDS Conference (Geneva). Geneva, Switzerland. Abstract 22261
- Kreek, M J. Physiologic implications of methadone maintenance treatment. Proceedings of the Fifth National Conference of Methadone Treatment NAPAN II-NIMH. pp.824–836.
- Cushman P, 1974, NY State J Med., 74, 1970
- Des Jarlais D C, 1984, MMWR Morb Mortal Wkly Rep., 33, 377
- Novick D M, 1986, NIDA Res Monogr., 67, 318
- 1999, Centers for Disease Control HIV/AIDS Surveillance Report., 1, 11
Cited by
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
“135 Because adolescents often have shorter addiction history, it is not known whether they would require maintenance pharmacotherapy.”
BackgroundHistory and current status of opioid maintenance treatments: blending conference session
Kreek, M. J., & Vocci, F. J. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00259-3 · Cited by 131
“Of considerable concern, a very recent study has shown that essentially all of the former heroin addicts in methadone maintenance treatment who are HIV positive, and thus require treatment of AIDS infection, also have markers indicating prior or current hepatitis C infection (Piccolo et al., 2001).”
BackgroundSelf-citationGenomewide suggestive linkage of opioid dependence to chromosome 14q
Lachman, H. M., Fann, C. S. J., Bartzis, M., Evgrafov, O. V., Rosenthal, R. N., Nunes, E. V., Miner, C., Santana, M., Gaffney, J., Riddick, A., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm081 · Cited by 95
“Although statistics vary in different parts of the USA, approximately one-fifth of intravenous users of heroin are infected with human immunodeficiency virus and three-quarters with hepatitis C virus (2).”
BackgroundCritical issues in the treatment of hepatitis C virus infection in methadone maintenance patients
Novick, D. M., & Kreek, M. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02188.x · Cited by 86
Self-citationPopulation Pharmacokinetics of Heroin and its Major Metabolites
Rook, E. J., Huitema, A. D. R., van den Brink, W., van Ree, J. M., & Beijnen, J. H. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645040-00005 · Cited by 82
Knowledge of and interest in hepatitis C treatment at a methadone clinic
Walley, A. Y., White, M. C., Kushel, M., Song, Y. S., & Tulsky, J. P. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.12.004 · Cited by 81
“About 20% of the 810,000 heroin users in the United States receive treatment for opiate dependence at methadone programs, and HCV prevalence among methadone clients is reported to be 66–93% (Best et al., 1999; Dhopesh, Taylor, & Burke, 2000; Murrill et al., 2002; Piccolo et al., 2002).”
BackgroundTien, P. C. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00222.x · Cited by 81
“The majority (nearly 100%) of HIV-infected hemophiliacs in the Unites States are HCV-infected (3), compared to a range of 50–90% of HIV-infected injection drug users (4), and about 2–14% who acquired HIV via sexual contact (5, 6).”
BackgroundWang, X., Zhang, T., & Ho, W. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9296-1 · Cited by 62
“High HCV seroprevalence exists at methadone maintenance (MM) programs, ranging from 67% to 96% (Chamot et al. 1992; Chetwynd et al. 1995; Crofts et al. 1997; McCarthy and Flynn 2001; Novick et al. 1997; Piccolo et al. 2002; Selvey et al. 1997).”
Bart, G., Piccolo, P., Zhang, L., Jacobson, I., Schaefer, R. A., & Kreek, M. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02151.x · Cited by 25
“In a previous report we also found that older age at time of entry into methadone maintenance was associated with an increased prevalence of HCV [7].”
Self-citationNyamathi, A., Tyler, D., Sinha, K., Marfisee, M., Cohen, A. J., & Greengold, B. (2010) · Journal of Community Health · doi:10.1007/s10900-010-9266-1 · Cited by 23
“) and internationally have revealed that 85–95% of MMT individuals have at least one marker for HBV infection, while 60–98% are anti-HCV positive [1–6].”
BackgroundBerk, S. I., Litwin, A. H., Arnsten, J. H., Du, E. Y., Soloway, I. J., & Gourevitch, M. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.009 · Cited by 23
Awareness of Hepatitis C Infection Among Women With and At Risk for HIV
Cohen, M. H., Grey, D. D., Cook, J. Α., Anastos, K., Seaberg, E. C., Augenbraun, M. H., Burian, P., Peters, M. G., Young, M., & French, A. L. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0395-x · Cited by 17
Interventions for HIV and Hepatitis C Virus Infections in Recreational Drug Users
Khalsa, J. H., & Elkashef, A. M. (2010) · Clinical Infectious Diseases · doi:10.1086/652447 · Cited by 15
“lence and age at admission into an MMT program [59].”
BackgroundTaylor, L. E., Bowman, S. E., Chapman, S., Zaller, N. D., Stein, M. D., Cioe, P. A., Maynard, M. A., & McGovern, B. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.016 · Cited by 12
“Among HIV-infected U.S. persons reporting IDU as their route of exposure, HCV coinfection rates range from 26% to 85% (Piccolo et al., 2002; Sherman et al., 2002; Sulkowski and Thomas, 2003).”
BackgroundDubois, N., Demaret, I., Ansseau, M., Rozet, E., Hubert, P., & Charlier, C. (2013) · Acta Clinica Belgica · doi:10.2143/acb.3323 · Cited by 11
Haley, S. J., & Kreek, M. J. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302327 · Cited by 9
Self-citationPeles, E., Rados, V., & Adelson, M. (2007) · Substance Use & Misuse · doi:10.1080/10826080701212550 · Cited by 8
“This high prevalence is very common among MMT patients and may be even higher (Carter, Robinson, Hanlon, Hailwood, and Massarotto, 2001; Piccolo et al., 2002).”
BackgroundResultCorrelates of Depressive Symptoms among Alcohol‐Using Methadone Maintained Adults
Nyamathi, A., Albarrán, C. R., Branson, C. M., Marfisee, M., Khalilifard, F., & LEAKE, B. D. (2012) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00300.x · Cited by 6
Treating chronic hepatitis C in recovering opiate addicts: yes, we can
Kreek, M. J., Talal, A. H., & Piccolo, P. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.01.003 · Cited by 6
“[2] It is now well known that a history of intravenous drug use is the single strongest risk factor for acquiring HCV infection and that prevalence of HCV, particularly in IDUs greater than 40 years of age, is over 70%.[3-5]”
BackgroundSelf-citationA Primary Care/Multidisciplinary Harm Reduction Clinic Including Opiate Bridging
Ross, D. B., Lo, F., McKim, R., & Allan, G. M. (2008) · Substance Use & Misuse · doi:10.1080/10826080802241193 · Cited by 6
“Common demographics in substance misusers include polysubstance misuse (alcohol and stimulant use in addition to opiate use), concurrent Hepatitis C and HIV infection (Picollo et al., 2002), mental health problems (depression, anxiety), low income (homeless, unemployed) and finally, a high prevalence of incarceration…”
BackgroundVariation in the Viral Hepatitis and HIV Policies and Practices of Methadone Maintenance Programs
Jessop, A. B., Hom, J. K., & Burke, M. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000296 · Cited by 5
“The prevalence of HIV in PWID ranges from 5% to 13%, with some individual MMT programs reporting rates of HIV as high as 29% (Piccolo et al., 2002; CDC, 2009).”
BackgroundWetli, C. V. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch2 · Cited by 4
Diagnostic Usefulness of Liver Function Tests in Alcohol and Opioid Dependent Patients
Jain, R., & Varghese, S. T. (2005) · Addictive Disorders & Their Treatment · doi:10.1097/01.adt.0000155724.37245.9c · Cited by 4
“The acute phase of hepatitis C presents with elevated liver enzymes ASTand ALT, and this phase of illness is considered to be the best time for treatment intervention in them.(14)”
BackgroundMoreira, S. A., Morcos, P. N., Navarro, M. T., Bech, N., Smith, P. F., & Brennan, B. J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1341 · Cited by 3
Interprofessional Collaboration between Mental Health Counselors and Nurses
Ghassemi, A. E. (2017) · Creative Nursing · doi:10.1891/1078-4535.23.4.242 · Cited by 3
“246 Ghassemi Common demographics of substance misusers include polysubstance use (alcohol, stimulant use, opiate use), concurrent hepatitis C and HIV infection, mental health problems (depression and anxiety), and low income (unemployment and homelessness; Cronquist, Edwards, Galea, Latka, & Vlahov, 2001; Piccolo et a…”
BackgroundWhitehead, N. E., Hearn, L. E., Marsiske, M., Kahn, M. R., & Latimer, W. W. (2013) · Journal of Community Health · doi:10.1007/s10900-013-9782-x · Cited by 3
Ogawa, L. M. F. (2007) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ttrn-3v27 · Cited by 1
“Prevalence studies show HCV infection rates in injection drug users to be 67% (Piccolo et al, 2002), 76.9% (Garfein, Vlahov, Noya, Doherty, & Nelson, 1996), 89% (Thiede, Hagan, & Murrill, 2000), and 80% to 100% (Murrill et al., 2002).”
BackgroundMethodInfluentialBart, G. B. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Vocci, F. J. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn041
Substance Use and Co-Occurring Infections: An Overview
Khalsa, J. H., Bough, K. J., Chand, N., Gyaw, S., & Lao, G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_82
Myocardial Alterations in Drug Abusers
Karch, S. B. (2007) · CRC Press eBooks · doi:10.1201/9781420054569.ch5
Hepatitis C testing among young people who experience homelessness in Melbourne
Myers, P. (2007) · Minerva Access (University of Melbourne)
Hasanovic, M. I., Sutović, A., Avdibegović, E., Pajević, I., Kuldija, A., Delić, A., & Aljukic, N. (2013) · International Journal of Sciences · doi:10.5281/zenodo.3348484
Metadata
- Authors
- Piccolo, P., Borg, L., Lin, A., Melia, D., Ho, A., & Kreek, M. J.
- Affiliations
- University of Rome Tor Vergata (IT)
- NewYork–Presbyterian Hospital (US)
- Rockefeller University (US)
- Venue
- Journal of Addictive Diseases
- Publisher
- Informa UK Limited
- Published
- 2002-09-20
- Volume
- 21
- Issue
- 4
- Pages
- 55-66
- ISSN
- 1055-0887 (ISSN-L)
- 1545-0848
- OpenAlex
- W2021537616
- Cited by
- 32
- References
- 37
- Citations by year
- 2017: 2 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Addictive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2m01rr000102-41)
- National Institute on Drug Abuse (K05 DA00049, P50DA005130, K05DA000049, P50 DA 05130)
- National Center for Research Resources (M0-1 RR00102)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- hepatitis C virus, HIV-1, HIV/HCV coinfection, methadone maintenance treatment, heroin addiction, opioid use disorder, seroprevalence, age at admission, risk reduction education
- MeSH terms
- Adult, Hepatitis C, Humans, Methadone, New York, HIV-1, HIV Infections, Substance Abuse, Intravenous, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.